Release history
Corrections are part of the record.
The original v1.0.0 snapshot is superseded. Its unverified review labels and withdrawn scores must not be treated as current benchmarks.
v1.0.26 · 2026-10-27
Recorded changes:
- SS-AIDT-2026-0023: Autonomous publication under the active October 8 delegation: LSEG agreed to acquire Octus for $3.535 billion, including proprietary private-credit documents, structured data, expert intelligence, analytics and AI-enabled workflows. Knowledge and Professional Workflow apply; Human Response is not applicable; strict data-rights qualification is true. The Asset Score is 90 with 100% coverage and the Transaction Signal Score is 77 with 85% coverage under methodology v1.0.0.
v1.0.25 · 2026-10-27
Recorded changes:
- SS-AIDT-2026-0019: Owner-approved participant and source update to existing SS-AIDT-2026-0019: Reach plc joins the same paid Google News AI pilot through enhanced content rights across its UK and Ireland portfolio. No duplicate transaction is created, scores are unchanged, and training and other undisclosed rights remain undisclosed.
v1.0.24 · 2026-10-27
Recorded changes:
- SS-AIDT-2026-0022: Owner-approved publication under the locked methodology: MassiveMusic licenses a separate dedicated opt-in dataset, approved by rightsholders specifically for training GRAI's music foundation model. The streaming catalog, recommendation metadata and patent license are excluded; financial terms remain undisclosed.
v1.0.23 · 2026-10-27
Recorded changes:
- SS-AIDT-2026-0021: Owner-approved publication under the locked methodology: Tempus licenses up to 500,000 de-identified neurology records and the Tempus Agent to Pathos over five years, with up to $55 million in disclosed fees and explicit sublicense rights to BMS. Realized delivery and training rights remain undisclosed.
v1.0.22 · 2026-10-27
Recorded changes:
- SS-AIDT-2026-0020: Owner-approved publication under the locked methodology: Tempus licenses de-identified multimodal oncology records and related analysis access to Bristol Myers Squibb under a multi-year agreement with $137.5 million of fixed contractual payments. The separate Pathos neurology license is not combined, and undisclosed training rights remain undisclosed.
v1.0.21 · 2026-10-16
Recorded changes:
- SS-AIDT-2026-0019: Autonomous publication under the active October 8 delegation: more than 400 participating publications license enhanced proprietary news content to Google's paid News AI pilot for AI article overviews and customizable audio briefings with attribution and links. CNN separately confirms a compensated multi-year agreement. Knowledge applies; Professional Workflow and Human Response remain unknown. Strict data-rights qualification is true, with AI Data Asset Score 81 and Transaction Signal Score 68. Undisclosed rights remain explicitly not disclosed.
v1.0.20 · 2026-10-07
Recorded changes:
- SS-AIDT-2026-0016: Mike Ye approved the OpenAI × Synopsys wording correction. Strict data-rights qualification remains true and AI Data Asset Score 94 / Transaction Signal Score 74 are unchanged. The analysis boundary now aligns with the canonical registry: Professional Workflow remains unknown absent a separately approved capability-flow classification; executable tool access is not converted into that facet by narrative inference.
v1.0.19 · 2026-10-07
Recorded changes:
- SS-AIDT-2026-0017: Mike Ye approved the OpenAI × Ironclad canonical AI Access event as strict data-rights qualified. Ironclad supplied expert contracting workflows, evaluation rubrics and hosted software environments for GPT-6 Astra training and evaluation using synthetic public-contract tasks rather than customer contracts. AI Data Asset Score 93; Transaction Signal Score 63.
v1.0.18 · 2026-10-07
Recorded changes:
- SS-AIDT-2026-0018: Mike Ye approved the Biohub Virtual Biology canonical AI Access event as strict data-rights qualified. Commercial funders receive a one-year embargo advantage on AI-ready biological data they help fund before public release, with explicit predictive-model training use. AI Data Asset Score 94; Transaction Signal Score 84.
v1.0.17 · 2026-10-01
Recorded changes:
- SS-AIDT-2026-0016: Mike Ye approved the OpenAI × Synopsys GPT-Synopsys canonical AI Access event as strict data-rights qualified. OpenAI receives licensed access to Synopsys proprietary EDA tools and expert workflows for model training; customer data is excluded from training. AI Data Asset Score 94; Transaction Signal Score 74.
v1.0.16 · 2026-10-01
Recorded changes:
- SS-AIDT-2026-0015: Mike Ye approved the Ginkgo Datapoints/Apheris Antibody Developability Consortium canonical AI Access event as strict data-rights qualified. The arrangement provides governed federated learning rights over proprietary antibody sequences and standardized assay data while members retain ownership and raw sequences remain protected. AI Data Asset Score 90; Transaction Signal Score 51.
v1.0.15 · 2026-09-30
Recorded changes:
- SS-AIDT-2026-0014: Withdraw unsupported USD currency attribution; the reviewed issuer announcement states seven-figure consideration without an explicit currency or payment form. Preserve the record, rights analysis and prior immutable releases.
v1.0.14 · 2026-09-30
Recorded changes:
- SS-AIDT-2026-0011: Correct source-stated first disclosure to September 15, 2026 and distinguish the September 23 infrastructure announcement. Preserve uncertainty about execution dates and original page publication history; do not count this as an in-horizon new transaction.
v1.0.13 · 2026-09-30
Recorded changes:
- SS-AIDT-2026-0014: Mike Ye approved the OneMedNet seven-figure multiyear clinical real-world-data license as a strict data-rights-qualified AI Access event. The record preserves explicit AI-model training, derivative-dataset commercialization, recurring downstream sublicensing economics and retained source-data rights; Human Response H2/H3 is not established.
v1.0.12 · 2026-09-29
Recorded changes:
- SS-AIDT-2026-0013: Mike Ye approved the vRad → GuideAI Health canonical AI Access data-rights arrangement. GuideAI retains exclusive rights to develop AI models using de-identified imaging generated across more than 2,100 U.S. hospitals and healthcare facilities, expressly for training and validating vascular-disease algorithms. Economics, term length, retention, sublicensing and detailed derived-model ownership remain undisclosed; Human Response is not established.
v1.0.11 · 2026-09-29
Recorded changes:
- SS-AIDT-2026-0012: Mike Ye approved the Tempus AI → Recursion Pharmaceuticals canonical AI Access data-rights arrangement. Tempus's proprietary de-identified clinical and molecular oncology corpus is licensed for explicit AI/ML training, improvement, modification and derivative-model work. The September 2026 amendment extends the same arrangement to six years, removes convenience termination, reduces the aggregate unique-record cap and resets the remaining third-through-fifth anniversary fees to $14 million each. Human Response is not established; this is not a second event.
v1.0.10 · 2026-09-27
Recorded changes:
- SS-AIDT-2026-0011: Mike Ye approved the Harell Data controlled-learning transaction. Proprietary A-Alpha Bio and Adaptive Biotechnologies scientific datasets are available for governed in-place training, fine-tuning, validation, and inference; raw data remains non-extractable, model builders retain resulting model IP, and data owners receive per-training-run revenue share. Exact pricing, share percentages, retention, exclusivity, sublicensing, geography, and independent model uplift remain undisclosed.
v1.0.9 · 2026-09-17
Recorded changes:
- SS-AIDT-2026-0010: Approved for publication as reviewed.
v1.0.8 · 2026-09-17
Recorded changes:
- SS-AIDT-2026-0009: Approved for publication as reviewed.
v1.0.7 · 2026-09-17
Recorded changes:
- SS-AIDT-2026-0008: Approved for publication as reviewed.
v1.0.6 · 2026-09-16
Recorded changes:
- SS-AIDT-2025-0001: Owner approved corrected OpenFold consortium expansion: undisclosed economics and consortium-reported model improvement explicitly distinguished from independent replication.
v1.0.5 · 2026-09-16
Recorded changes:
- SS-AIDT-2025-0002: Owner approved Tempus–Pathos: contractual data-license fees, alternative equity settlement and separate linked obligations preserved; current payment performance unverified.
v1.0.4 · 2026-09-16
Recorded changes:
- Allow explicit unknown asset disposition and corpus renewal instead of forcing an unsupported classification. No transaction records, scores, or approvals changed.
v1.0.3 · 2026-09-16
Recorded changes:
- SS-AIDT-2026-0007: Mike Ye approved the TotalEnergies / Mistral record and Asset / Signal scores of 85 / 56 in the owner conversation. The greater-than-EUR100m commitment covers the broader program, not a separately priced dataset.
v1.0.2 · 2026-09-16
Recorded changes:
- SS-AIDT-2026-0004: Mike Ye approved the NAVER consortium record and Asset / Signal scores of 81 / 35 in the owner conversation. Model co-development; dataset cash price undisclosed; no confirmed federated topology or outright ownership transfer.
v1.0.1 · 2026-09-16
Recorded changes:
- Marked all eight legacy observations provisional because no revision-specific human approvals were recorded.
- Withdrew legacy scores pending factor-level evidence and compliance with the published half-point scale.
- Corrected NAVER membership from 32 to 33 based on its announcement.
- Reclassified the Stretto research summary as secondary evidence.
- Preserved v1.0.0 unchanged as a superseded snapshot; new candidates cannot publish without authenticated approval.
v1.0.0 · 2026-09-15
Superseded historical snapshot; review claims and scores subsequently withdrawn.
- Established the canonical transaction schema and eight-category primary taxonomy.
- Published separate AI Data Asset and Transaction Signal scores.
- Seeded eight verified observations from 2025–2026.
- Created a rejection ledger for plausible but non-qualifying signals.
- Defined a machine-ingestible candidate record and mandatory human-review gate.